Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Prymula

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Lancet (London, England)|October 20, 2009
Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trialsRoman Prymula, Claire-Anne Siegrist, Roman Chlibek, et al.
Plos One|August 14, 2013
Clinical and economic burden of community-acquired pneumonia among adults in the Czech Republic, Hungary, Poland and SlovakiaAles Tichopad, Craig Roberts, Igor Gembula, et al.
Vaccine|January 11, 2011
Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriageRoman Prymula, Irena Hanovcova, Miroslav Splino, et al.
Lancet (London, England)|March 7, 2006
Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy studyRoman Prymula, Pascal Peeters, Viktor Chrobok, et al.
Vaccine|June 12, 2010
Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in EuropeTimo Vesikari, Aino Karvonen, Roman Prymula, et al.
Human Vaccines & Immunotherapeutics|June 16, 2012
Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® JuniorRoman Prymula, Eva Maria Pöllabauer, Borislava G Pavlova, et al.
Molecules (Basel, Switzerland)|January 5, 2018
Rational Design of a New Class of Toll-Like Receptor 4 (TLR4) Tryptamine Related Agonists by Means of the Structure- and Ligand-Based Virtual Screening for Vaccine Adjuvant DiscoveryJan Honegr, Rafael Dolezal, David Malinak, et al.
Vaccine|August 26, 2018
Vaccination of 50+ adults to promote healthy ageing in Europe: The way forwardSusanna Esposito, Nicola Principi, Giovanni Rezza, et al.
Plos One|June 4, 2016
Comparative Epidemiologic Characteristics of Pertussis in 10 Central and Eastern European Countries, 2000-2013Ulrich Heininger, Philippe André, Roman Chlibek, et al.
Central European Journal of Public Health|March 6, 2014
Regional advisory board position statement on optimal pneumococcal vaccination in adults. Update to 2011 consensus on adult pneumococcal disease: update on optimal pneumococcal vaccination in adultsEndre Ludwig, Serhat Unal, Miron Bogdan, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|October 20, 2009
Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trialsRoman Prymula, Claire-Anne Siegrist, Roman Chlibek, et al.
Plos One|August 14, 2013
Clinical and economic burden of community-acquired pneumonia among adults in the Czech Republic, Hungary, Poland and SlovakiaAles Tichopad, Craig Roberts, Igor Gembula, et al.
Vaccine|January 11, 2011
Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriageRoman Prymula, Irena Hanovcova, Miroslav Splino, et al.
Lancet (London, England)|March 7, 2006
Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy studyRoman Prymula, Pascal Peeters, Viktor Chrobok, et al.
Vaccine|June 12, 2010
Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in EuropeTimo Vesikari, Aino Karvonen, Roman Prymula, et al.
Human Vaccines & Immunotherapeutics|June 16, 2012
Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® JuniorRoman Prymula, Eva Maria Pöllabauer, Borislava G Pavlova, et al.
Molecules (Basel, Switzerland)|January 5, 2018
Rational Design of a New Class of Toll-Like Receptor 4 (TLR4) Tryptamine Related Agonists by Means of the Structure- and Ligand-Based Virtual Screening for Vaccine Adjuvant DiscoveryJan Honegr, Rafael Dolezal, David Malinak, et al.
Vaccine|August 26, 2018
Vaccination of 50+ adults to promote healthy ageing in Europe: The way forwardSusanna Esposito, Nicola Principi, Giovanni Rezza, et al.
Plos One|June 4, 2016
Comparative Epidemiologic Characteristics of Pertussis in 10 Central and Eastern European Countries, 2000-2013Ulrich Heininger, Philippe André, Roman Chlibek, et al.
Central European Journal of Public Health|March 6, 2014
Regional advisory board position statement on optimal pneumococcal vaccination in adults. Update to 2011 consensus on adult pneumococcal disease: update on optimal pneumococcal vaccination in adultsEndre Ludwig, Serhat Unal, Miron Bogdan, et al.
Pageof 8